STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 81 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $51,000 | -61.1% | 10,612 | -13.9% | 0.00% | – |
Q4 2019 | $131,000 | 0.0% | 12,328 | -1.9% | 0.00% | – |
Q3 2019 | $131,000 | -24.3% | 12,571 | +16.4% | 0.00% | – |
Q2 2018 | $173,000 | +7.5% | 10,803 | +2.7% | 0.00% | – |
Q1 2018 | $161,000 | -4.7% | 10,523 | -3.0% | 0.00% | – |
Q4 2017 | $169,000 | -29.0% | 10,846 | -34.1% | 0.00% | – |
Q1 2015 | $238,000 | -13.8% | 16,457 | +1.9% | 0.00% | -100.0% |
Q4 2014 | $276,000 | – | 16,150 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
QVT Financial LP | 220,000 | $9,965,000 | 0.68% |
Healthcare Value Capital, LLC | 16,464 | $746,000 | 0.65% |
EAM Investors, LLC | 69,151 | $3,132,000 | 0.62% |
Baker Brothers Advisors | 800,400 | $36,255,000 | 0.52% |
Spark Investment Management LLC | 38,300 | $1,733,000 | 0.40% |
Perceptive Advisors | 180,416 | $8,172,000 | 0.34% |
SIGMA CAPITAL MANAGEMENT LLC | 175,000 | $7,926,000 | 0.33% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 129,915 | $5,885,000 | 0.23% |
Visium Asset Management, LP | 150,000 | $6,794,000 | 0.15% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 19,732 | $894,000 | 0.14% |